Preoperative staging of rectal cancer by endoluminal ultrasound vs. magnetic resonance imaging. Preliminary results of a prospective, comparative study.

Second Department of Surgery, Regional Hospital of Bolzano, Italy.
Diseases of the Colon & Rectum (Impact Factor: 3.2). 01/1995; 37(12):1189-93.
Source: PubMed

ABSTRACT The aim of this study was to compare the value of endoluminal ultrasonography (ELUS) with magnetic resonance imaging (MRI) for preoperative staging of rectal carcinoma.
Thirty-seven consecutive patients were examined by ELUS and MRI. Imaging results were compared with pathohistologic studies. A tumor extending beyond the bowel wall was considered to be "positive" and one within the bowel wall was considered "negative." Lymph node involvement was considered present if nodes equal to or greater than 5 mm in diameter were found in the perirectal tissue. For evaluating the differences between the two methods, the Mc Nemar test was performed.
T-Staging was correct in 88.2 percent (30/34) of patients by ELUS and in 82.3 percent (28/34) by MRI (difference not significant). N-Staging was correct in 80 percent (20/25) by ELUS and in 60 percent (15/25) by MRI (difference of borderline significance). A comprehensive preoperative staging (T + N) was made correctly in 68 percent (17/25) by ELUS and in 48 percent only (12/25) by MRI (difference not significant).
We suggest that ELUS and MRI must be evaluated within the framework of established parameters when treatment modalities such as preoperative radiation therapy and local or radical surgical approach must be decided.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Résumé Le cancer colorectal est le cancer le plus fréquent de l’adulte en Europe et aux Etats-Unis. Chaque année plus de 38 000 nouveaux cas de cancer du rectum sont diagnostiqués aux Etats-Unis. De par sa localisation anatomique, le cancer du rectum doit être différencié du cancer du côlon. Ces différences anatomiques et pronostiques recommandent des stratégies diagnostiques et thérapeutiques relativement bien codifiées et basées sur le bilan d’extension locorégionale. Ce travail fait le point sur le rôle de l’échographie endorectale dans l’évaluation et la prise en charge thérapeutique des cancers du rectum.
    Acta Endoscopica 02/2007; 37(1):15-25. · 0.16 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Thirty to forty percent of villous adenomas can be an occult carcinoma. Even biopsy can miss the diagnosis. Rectal endosonography can be useful to detect these malignant tumors. Aim: To assess the usefulness of rectal endosonography to detect invasive carcinoma and eventual lymph node involvement in villous adenomas. Material and methods: Retrospective review of 1400 rectal endosonographies performed between years 2000 and 2006. Those cases in which a rectal villous adenoma was informed, that were subjected to surgical excisión and that had a pathology report were included in the study. Results: Thirty five rectal endosonographies were informed as rectal villous adenoma and 28 had a pathology report. In 17 of the latter, an invasive carcinoma was detected on pathology. The concordance between pathology and rectal endosonography to detect the carcinoma was 82%. Positive and negative predictive valúes, sensitivity and specificity of endosonography to detect carcinoma were 100, 69, 71 and 100% respectively. The concordance to differentiate T0-T1 lesions from deeper lesions and to detect lymph node involvement was 75 and 84% respectively. Conclusions: Rectal endosonography is useful to detect carcinomas in villous adenoma and to determine the stage of such tumors.
    Revista chilena de cirugía. 01/2008; 60(4).
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die Therapieentscheidung zwischen primärer Resektion, neoadjuvanter Therapie und lokaler Exzision hängt beim Rektumkarzinom von einem präzisen lokalen Staging ab. Das lokale Staging beinhaltet dabei die klinische Untersuchung, die starre Rektoskopie und die rektale Endosonographie (EUS). Die digital-rektale Palpation des Tumors ermöglicht eine Graduierung der Mobilität des Tumors, z. B. auf der Schleimhaut oder mit der Rektumwand. Die starre Rektoskopie ermittelt den aboralen Tumorabstand zur Linea dentata bzw. zur Anokutanline. Die rektale Endosonographie ermöglicht die Festlegung des prätherapeutischen UICC-Stadiums durch Evaluation der prätherapeutischen uT- und uN-Kategorie, mit z. T. heterogenen Resultaten. Eine differenzierte Betrachtung der Ergebnisse muss zudem die Wertigkeit der EUS im Vergleich zur Magnetresonanztomographie (MRT) und die Interpretation der Befunde nach neoadjuvanter Therapie einschließen. Darüber hinaus bietet die EUS nur unzureichende Informationen bez. des Tumorabstandes zur zirkumferenziellen Resektionsebene. Technische Verbesserungen, wie die 3D-EUS, sind möglicherweise geeignet, in Zukunft eine Verbesserung des endosonographischen Stagings in diesen Punkten zu liefern.
    Der Chirurg 05/2012; 83(5). · 0.52 Impact Factor